Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. - Wikidata - wikimedia - TriplyDB

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.

http://www.wikidata.org/entity/Q33853398

about

Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope The Canine Papillomavirus E5 Protein Signals from the Endoplasmic Reticulum Capsomer vaccines protect mice from vaginal challenge with human papillomavirus The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.Papillomavirus prophylactic vaccines: established successes, new approaches.Complete genome sequence of canine papillomavirus type 11.Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model.Subviral particle as vaccine and vaccine platform.Humoral immune response recognizes a complex set of epitopes on human papillomavirus type 6 l1 capsomers.Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection.HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future.Life cycle heterogeneity in animal models of human papillomavirus-associated disease Development of a highly thermostable, adjuvanted human papillomavirus vaccine.Prevention of cancer by prophylactic human papillomavirus vaccines.Interactions between papillomavirus L1 and L2 capsid proteins Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16 How will HPV vaccines affect cervical cancer?Complete genome sequence of canine papillomavirus virus type 12.Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma.Production of human papillomavirus type 16 virus-like particles in transgenic plants.Recent developments in human papillomavirus vaccines.Complete genome sequence of canine papillomavirus type 9.Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.Emerging human papillomavirus vaccines.A review of clinical trials of human papillomavirus prophylactic vaccines.Complete genome sequence of canine papillomavirus type 10 A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response Human papillomavirus therapeutic vaccines in head and neck tumors.Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.Listeria monocytogenes delivery of HPV-16 major capsid protein L1 induces systemic and mucosal cell-mediated CD4+ and CD8+ T-cell responses after oral immunization A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.Economic evaluations of human papillomavirus vaccines.Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes.Bioengineering virus-like particles as vaccines.Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice.Design strategies to address the effect of hydrophobic epitope on stability and in vitro assembly of modular virus-like particle Development of chimeric candidate vaccine against HPV18: a proof of concept.

P2860

Q24796150-BFBC5867-6A75-46CA-B8D4-24B3820390B9 Q27490470-2C652ECD-F431-4736-BAD4-B68054FDE73B Q28743261-57B5A0DA-A24F-419D-9F4B-AB9140DA2AF6 Q30989066-7448FCBD-9CFA-4C14-95E3-1095E80B9A6B Q33614425-70F15D9E-71E9-4118-91ED-80187447465A Q33687407-4CB01DFC-509A-4FB9-8F42-C98313F6D742 Q33723292-759AE5D7-8E29-4697-B90B-65DD277C7ACC Q33728320-F8BDC887-EB55-46B1-AC86-7E200E63CF50 Q33812653-17E22307-3321-479D-A740-5FA8B57DD1CA Q33908917-156B4F20-1AE3-4E58-989D-41A9C1D8BC23 Q34054427-1583704D-B5DD-46FB-BB16-39A4E08D8641 Q34335370-FE41DB4A-BE72-4FF9-ADF9-A73A8EDD1C9D Q34348189-72BDECD1-0BEC-4233-B7D6-0DCEB6830653 Q34477334-6BD6BBF9-2868-48CE-A0E6-EC3C0DB62F73 Q34762053-38F5DB0B-04DB-48AC-9836-89442FC3A5B4 Q34860943-4562C184-CEBA-4BDA-9BD3-83734EE9F9E9 Q35155333-21A1CCCD-7D2F-4279-9ED5-10707341064C Q35235035-85772AAA-E7BE-4CF8-9C4A-8028FEF0B3AF Q35452082-398FE2E7-457A-49DF-BC21-DC62D5FB91D6 Q35552591-F8127C78-638D-4077-94FC-8C818D228389 Q35802720-87B6C777-0E65-4088-8032-8499F83301E4 Q35842528-E64F0DB5-916A-485E-8840-BB57ED7324F9 Q35943543-CA72E59E-6804-4A70-9AC1-F5E4E60C64F3 Q35999402-4FDC22F8-E207-4A77-89A4-107E276E0D21 Q36066004-689AF41E-A931-47A6-BB30-4D399EEA0C00 Q36259403-C01D846F-DE5D-47CF-8FB7-25629EBE532F Q36276246-FC4A2A6C-F6C8-4897-B774-AAC5DB3D35BE Q36673310-B313A73D-9CF5-4956-A5AB-AD586C8A79A6 Q36817148-68F77B71-FB8D-427D-930B-CD0618534EA6 Q37242405-6A09DE4E-C187-4EB8-AA0B-AAA79D418375 Q37274559-395D8DF4-60D8-4360-B640-1FC6C507284D Q37307576-4872AFC2-0077-49E5-9EFA-7663A2378451 Q37391175-44A29A16-2D98-40ED-AB1E-8D8E78759948 Q37604412-EE8FAED3-894C-44AF-BDF3-4FF803A1B8B6 Q37763114-DE062A76-72B0-46B7-9917-85CE5C5C23A6 Q37859086-CFF400E3-3AD0-4AB4-98BA-21F9B75D7A9E Q38172045-23DD9954-926C-400A-8D40-8B61CAA725D9 Q39742082-3E53BE07-87CC-4D8A-A84A-CE3C59ADF6E8 Q40736884-14432E13-034A-4070-8D59-079F0F525FCA Q41269236-FC70AD36-B3E9-4FD0-A2FA-B8A0128BD782

P2860

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.

http://www.wikidata.org/entity/Q33853398

description

2001 nî lūn-bûn

@nan

2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Immunization with a pentameric ...... inst papillomavirus infection.

@ast

Immunization with a pentameric ...... inst papillomavirus infection.

@en

type

label

Immunization with a pentameric ...... inst papillomavirus infection.

@ast

Immunization with a pentameric ...... inst papillomavirus infection.

@en

prefLabel

Immunization with a pentameric ...... inst papillomavirus infection.

@ast

Immunization with a pentameric ...... inst papillomavirus infection.

@en

P1433

Q33853398-7214266F-6C40-46E4-B7C2-D38A383D44CF

P1476

Q33853398-901DD472-A6CA-4582-9168-A713A4883DF0

P2093

Q33853398-08B180C7-6D81-4E44-A9D9-86DDC0AA57C9

Q33853398-1D1DD534-F684-4C09-A8AB-D757A547EB9E

Q33853398-1D7C6D43-C3A4-4323-8106-97B0FC8A32A1

Q33853398-26BA37DD-554D-47EE-B18E-0C9AF27C36DA

Q33853398-3377F6C0-3262-4BCE-BBD4-C000816887B1

Q33853398-EE1DD8DF-90FA-44AC-AA3C-C97480692C72

Q33853398-F9D70A64-AF04-4FF5-95CF-146DB897FC20

P2860

Q33853398-015FB0E8-51A0-4BD6-8744-D001F96FEA03

Q33853398-1821D9AD-DBE3-4427-8D37-0D8A3D1E9FE2

Q33853398-1AA6ED47-650F-4EA3-8631-8A78AC7CC1F7

Q33853398-2A69546C-28DF-4BE6-8C7F-6E0CA48715E9

Q33853398-34CBD5E4-7960-4FBD-BA55-8C47915287FD

Q33853398-4004AE7C-B969-4476-BAD3-E65683271EBA

Q33853398-42C1383F-BAED-42B4-9792-3EC80AB50DD5

Q33853398-4B06CB04-15AE-4266-806F-15097439B08C

Q33853398-4BDD0B4C-50BA-47BE-8BE1-CAAC4D9FFECD

Q33853398-59962AA0-C471-458B-BE14-CE42DDB092EE

P304

Q33853398-FF9A8FAD-5322-4F99-BE1F-03A915328D79

P31

Q33853398-ADDDEC9B-F448-4B44-84C4-F9936368EA1F

P356

Q33853398-380CE4A0-6DF8-40A5-ABB5-95C8FAD5A7C4

P433

Q33853398-18E61CE5-9E3F-451D-A15B-C38EBD270009

P478

Q33853398-66DD3592-19B9-4E3C-BC9D-9C0417FD0BF0

P577

Q33853398-0A5313E5-B561-428D-9648-53767DE76213

P5875

Q33853398-9F64D9FD-4B86-4E34-8ED8-7D54B3D00C94

P698

Q33853398-0C5F641D-41FB-4283-9913-0178F1D14051

P921

Q33853398-3B134ADD-8C39-4ED6-9D0B-508CADC5A175

P932

Q33853398-EA552665-1F56-4E0B-B005-C58BCDBE305B

P356

JVI.75.17.7848-7853.2001

P1433

Journal of Virology

P1476

Immunization with a pentameric ...... inst papillomavirus infection.

@en

P2093

H Yuan

http://www.w3.org/2001/XMLSchema#string

J Newsome

http://www.w3.org/2001/XMLSchema#string

P A Estes

http://www.w3.org/2001/XMLSchema#string

R L Garcea

http://www.w3.org/2001/XMLSchema#string

R Schlegel

http://www.w3.org/2001/XMLSchema#string

V A Olcese

http://www.w3.org/2001/XMLSchema#string

Y Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

Mucosotropic papillomavirus infections.

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.

The immunology of animal papillomaviruses.

Human papillomavirus vaccines.

Self-assembly of purified polyomavirus capsid protein VP1.

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.

Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly

P304

7848-7853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.75.17.7848-7853.2001

http://www.w3.org/2001/XMLSchema#string

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

2001-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11858861

http://www.w3.org/2001/XMLSchema#string

P698

11483728

http://www.w3.org/2001/XMLSchema#string

P921

P932

115027

http://www.w3.org/2001/XMLSchema#string